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INTRODUCTION
Currently, type 1 diabetes (T1D) is defined by the autoimmune destruction of the pancreatic β cells that 
culminates in dependence on exogenous insulin, typically 1 to 3 years after diagnosis. This ability to 
maintain a residual function of pancreatic β cells is, however, heterogeneous, appearing to be worst if the 
disease is early diagnosed. Recently, it was demonstrated that many type 1 diabetic patients produce small 







T1DM with 18 years of duration
- reasonable metabolic control 
- no known complications
- Insulin pump (0,6u/kg/day)
Hypertension and dyslipidemia (linisopril and
rosuvastatin)






Diagnosed with diabetes at age 19. 
- chronic poor metabolic control
- irregular treatment with oral antidiabetic 
agents (metformin, sitagliptin and gliclazide)
Family history of diabetes (mother and uncles))
positive anti-GAD
antibodies
(120,0 U/mL ; N:<10)
measurable C-peptide
(0,39 ng/mL; N: 0,8 – 6,0)
insulin therapy / lack of 
therapeutic adesion







(transferred to our hospital)
nil per os for 7 days during postoperative period
under glycosylated fluids (150gr/daily)
DISCUSSION 
The residual insulin production, detectable by the assay of C-peptide and its functional and clinical significance have
been recently discussed. According to recent evidence, these cases show us that insulin production in type 1 diabetic
patients can be kept for many years after diagnosis and that the end of the “honey-moon phase" does not necessarily
lead to the absence of insulin production.
refered to Endocrinology consultation 
- poor metabolic control (HbA1c 14,8%) 
- lack of therapeutic adesion
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Glycemia D1 D2 D3 D4 D5 D6 D7 D8 D9 D10
7h 218 225 178 180 186 210 152 134 125
12h 174 186 187 162 142 97 113 122
18h 226 100 156 133 150 159
23h 260 210 181 171 147 159 145
without exogenous insulin administration for 7 days
controlled blood glucose levels 
without acidemia and ketonemia
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